BCL9L and colorectal cancer: This comprehensive genomic analysis of aneuploid colorectal cancer identified frequent mutations and deletions of BCL9L leading to caspase-2 dysfunction and the tolerance of chromosome missegregation, which operates independently of TP53 status.